That's one of the conclusions of a new survey report by Decision Resources.
When treating newly diagnosed bipolar disorder patients, primary care physicians prescribe very differently from psychiatrists. That's one of the conclusions of a new survey report by market research firm Decision Resources. The Waltham, Mass., firm found that primary care physicians often order selective serotonin reuptake inhibitors, such as Forest Laboratories' escitalopram (Lexapro), as first-line treatment, while psychiatrists usually prefer lamotrigine (Lamictal, GlaxoSmithKline). The survey also found that nearly half of the patients taking SSRIs first line receive these drugs as monotherapy even though clinical guideline recommendations call for giving bipolar patients presenting with depression an antimanic first line. The report noted that the number of primary care physicians who are diagnosing and treating bipolar patients has been on the rise in recent years.
To see more Daily News articles, click here.
To go to the Drug Topics homepage, clickhere.
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
Assessing Financial Impacts of Pharmacist-Led Interventions in Pediatric Ambulatory Care
December 5th 2023According to a poster abstract presented at the ASHP Midyear Clinical Meeting & Exhibition, specialty pharmacy services were used for a variety of conditions that have been reported in adult populations.